Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
P Schöffski, B Besse, T Gauler, et al.
Radiation Oncology (London, England)
|
March 24, 2021
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
C Pöttgen, E Gkika, M Stahl, et al.
World Journal of Urology
|
May 13, 2022
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
V Grünwald, L Bergmann, B Brehmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
M Guberina, W Eberhardt, M Stuschke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
July 18, 2013
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results
P Heusch, C Buchbender, J Köhler, et al.
Radiation Oncology (London, England)
|
January 8, 2024
Prospects for online adaptive radiation therapy (ART) for head and neck cancer
Maja Guberina, Nika Guberina, C Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 17, 2019
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
K Klinghammer, T Gauler, A Dietz, et al.
European Journal of Medical Research
|
April 6, 2011
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy
Patrick J Schuler, V Börger, E Bölke, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 2, 2017
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer
M H Diekstra, A Fritsch, F Kanefendt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
P Schöffski, B Besse, T Gauler, et al.
Radiation Oncology (London, England)
|
March 24, 2021
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
C Pöttgen, E Gkika, M Stahl, et al.
World Journal of Urology
|
May 13, 2022
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
V Grünwald, L Bergmann, B Brehmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
M Guberina, W Eberhardt, M Stuschke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
July 18, 2013
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results
P Heusch, C Buchbender, J Köhler, et al.
Radiation Oncology (London, England)
|
January 8, 2024
Prospects for online adaptive radiation therapy (ART) for head and neck cancer
Maja Guberina, Nika Guberina, C Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 17, 2019
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
K Klinghammer, T Gauler, A Dietz, et al.
European Journal of Medical Research
|
April 6, 2011
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy
Patrick J Schuler, V Börger, E Bölke, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 2, 2017
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer
M H Diekstra, A Fritsch, F Kanefendt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Page
of 3